Company intelligence / Profile preview

Isolation Bio

San Carlos, California, United Statesisolationbio.com ↗

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

Isolation Bio has developed the Prospector® high-throughput cultivation platform that automates the isolation and screening of thousands of bacterial microcolonies in parallel. This enables researchers to discover previously uncultivated microbes from complex samples such as the human microbiome or environmental sources. The technology accelerates discovery in microbiome science by making rare or difficult-to-culture organisms accessible at scale.

No clinical results are reported as the company does not develop therapeutics itself.

Modalities: Microbial therapy (enabling technology for live biotherapeutic product therapy and microbial discovery)Device (high-throughput microbiology platform)Service (microbial isolation/cultivation services)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Isolation Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isolation Bio.

Explore the full profile